The US Food and Drug Administration has given its approval for Johnson & Johnson’ levofloxacin drug for preventing and treating plague. The FDA said that the drug has been approved for reducing the risk of plague after a person has been exposed to bacterium Yersinia pestis.
The drug, to be sold under the brand name Levaquin, was developed by Johnson & Johnson after the company was approached by the US government following fears that Yersinia pestis could be used as a biological weapon by terrorists.
Source-Medindia